Ballantyne Charles Evan 4
4 · CLINICAL DATA INC · Filed Dec 22, 2009
Insider Transaction Report
Form 4
Ballantyne Charles Evan
EVP, CFO
Transactions
- Award
Stock Option (Right to Buy)
2009-12-21+75,000→ 75,000 totalExercise: $18.39Exp: 2019-12-21→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Exercisable as to 25,000 shares on December 21, 2010, as to an additonal 25,000 shares on December 21, 2011, and as to an additional 25,000 shares on December 21, 2012. Such options shall become immediately exercisable, among other events, upon a change of control of the issuer.